846 related articles for article (PubMed ID: 25818251)
1. GLP-1 analog liraglutide protects against cardiac steatosis, oxidative stress and apoptosis in streptozotocin-induced diabetic rats.
Inoue T; Inoguchi T; Sonoda N; Hendarto H; Makimura H; Sasaki S; Yokomizo H; Fujimura Y; Miura D; Takayanagi R
Atherosclerosis; 2015 May; 240(1):250-9. PubMed ID: 25818251
[TBL] [Abstract][Full Text] [Related]
2. GLP-1 analog liraglutide protects against oxidative stress and albuminuria in streptozotocin-induced diabetic rats via protein kinase A-mediated inhibition of renal NAD(P)H oxidases.
Hendarto H; Inoguchi T; Maeda Y; Ikeda N; Zheng J; Takei R; Yokomizo H; Hirata E; Sonoda N; Takayanagi R
Metabolism; 2012 Oct; 61(10):1422-34. PubMed ID: 22554832
[TBL] [Abstract][Full Text] [Related]
3. Metformin and liraglutide ameliorate high glucose-induced oxidative stress via inhibition of PKC-NAD(P)H oxidase pathway in human aortic endothelial cells.
Batchuluun B; Inoguchi T; Sonoda N; Sasaki S; Inoue T; Fujimura Y; Miura D; Takayanagi R
Atherosclerosis; 2014 Jan; 232(1):156-64. PubMed ID: 24401231
[TBL] [Abstract][Full Text] [Related]
4. Curcumin prevents diabetic cardiomyopathy in streptozotocin-induced diabetic rats: possible involvement of PKC-MAPK signaling pathway.
Soetikno V; Sari FR; Sukumaran V; Lakshmanan AP; Mito S; Harima M; Thandavarayan RA; Suzuki K; Nagata M; Takagi R; Watanabe K
Eur J Pharm Sci; 2012 Oct; 47(3):604-14. PubMed ID: 22564708
[TBL] [Abstract][Full Text] [Related]
5. Fibroblast growth factor-21 prevents diabetic cardiomyopathy via AMPK-mediated antioxidation and lipid-lowering effects in the heart.
Yang H; Feng A; Lin S; Yu L; Lin X; Yan X; Lu X; Zhang C
Cell Death Dis; 2018 Feb; 9(2):227. PubMed ID: 29445083
[TBL] [Abstract][Full Text] [Related]
6. Insulin downregulates SIRT1 and AMPK activation and is associated with changes in liver fat, but not in inflammation and mitochondrial oxidative capacity, in streptozotocin-diabetic rat.
Barazzoni R; Zanetti M; Sturnega M; Stebel M; Semolic A; Pirulli A; Vinci P; Zentilin L; Giacca M; Cattin L; Guarnieri G
Clin Nutr; 2011 Jun; 30(3):384-90. PubMed ID: 21106280
[TBL] [Abstract][Full Text] [Related]
7. Monoamine oxidase-A is an important source of oxidative stress and promotes cardiac dysfunction, apoptosis, and fibrosis in diabetic cardiomyopathy.
Umbarkar P; Singh S; Arkat S; Bodhankar SL; Lohidasan S; Sitasawad SL
Free Radic Biol Med; 2015 Oct; 87():263-73. PubMed ID: 26122707
[TBL] [Abstract][Full Text] [Related]
8. Advanced glycation end-products impair Na⁺/K⁺-ATPase activity in diabetic cardiomyopathy: role of the adenosine monophosphate-activated protein kinase/sirtuin 1 pathway.
Yuan Q; Zhou QY; Liu D; Yu L; Zhan L; Li XJ; Peng HY; Zhang XL; Yuan XC
Clin Exp Pharmacol Physiol; 2014 Feb; 41(2):127-33. PubMed ID: 24341361
[TBL] [Abstract][Full Text] [Related]
9. Empagliflozin and Liraglutide Differentially Modulate Cardiac Metabolism in Diabetic Cardiomyopathy in Rats.
Trang NN; Chung CC; Lee TW; Cheng WL; Kao YH; Huang SY; Lee TI; Chen YJ
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33503985
[TBL] [Abstract][Full Text] [Related]
10. Fenofibrate increases cardiac autophagy via FGF21/SIRT1 and prevents fibrosis and inflammation in the hearts of Type 1 diabetic mice.
Zhang J; Cheng Y; Gu J; Wang S; Zhou S; Wang Y; Tan Y; Feng W; Fu Y; Mellen N; Cheng R; Ma J; Zhang C; Li Z; Cai L
Clin Sci (Lond); 2016 Apr; 130(8):625-41. PubMed ID: 26795437
[TBL] [Abstract][Full Text] [Related]
11. Effect of intervention in the diacylglycerol‑protein kinase C signaling pathway on JNK1 expression and its downstream signaling in diabetic cardiomyopathy.
Liu X; Qi F; Wu W
Mol Med Rep; 2014 Mar; 9(3):979-84. PubMed ID: 24435585
[TBL] [Abstract][Full Text] [Related]
12. Exendin-4 Protects against Hyperglycemia-Induced Cardiomyocyte Pyroptosis via the AMPK-TXNIP Pathway.
Wei H; Bu R; Yang Q; Jia J; Li T; Wang Q; Chen Y
J Diabetes Res; 2019; 2019():8905917. PubMed ID: 31886288
[TBL] [Abstract][Full Text] [Related]
13. Glucose fluctuations increase the incidence of atrial fibrillation in diabetic rats.
Saito S; Teshima Y; Fukui A; Kondo H; Nishio S; Nakagawa M; Saikawa T; Takahashi N
Cardiovasc Res; 2014 Oct; 104(1):5-14. PubMed ID: 25082849
[TBL] [Abstract][Full Text] [Related]
14. Effect of rosiglitazone on the expression of cardiac adiponectin receptors and NADPH oxidase in type 2 diabetic rats.
Guo Z; Qin Z; Zhang R; Li J; Yin Y
Eur J Pharmacol; 2012 Jun; 685(1-3):116-25. PubMed ID: 22542658
[TBL] [Abstract][Full Text] [Related]
15. Inhibiting microRNA-144 abates oxidative stress and reduces apoptosis in hearts of streptozotocin-induced diabetic mice.
Yu M; Liu Y; Zhang B; Shi Y; Cui L; Zhao X
Cardiovasc Pathol; 2015; 24(6):375-81. PubMed ID: 26164195
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective and anti-apoptotic effects of liraglutide in the rat brain following focal cerebral ischemia.
Briyal S; Shah S; Gulati A
Neuroscience; 2014 Dec; 281():269-81. PubMed ID: 25301749
[TBL] [Abstract][Full Text] [Related]
17. Curcumin alleviates diabetic cardiomyopathy in experimental diabetic rats.
Yu W; Wu J; Cai F; Xiang J; Zha W; Fan D; Guo S; Ming Z; Liu C
PLoS One; 2012; 7(12):e52013. PubMed ID: 23251674
[TBL] [Abstract][Full Text] [Related]
18. The glucagon-like peptide 1 analog liraglutide reduces TNF-α-induced oxidative stress and inflammation in endothelial cells.
Shiraki A; Oyama J; Komoda H; Asaka M; Komatsu A; Sakuma M; Kodama K; Sakamoto Y; Kotooka N; Hirase T; Node K
Atherosclerosis; 2012 Apr; 221(2):375-82. PubMed ID: 22284365
[TBL] [Abstract][Full Text] [Related]
19. Rosiglitazone reduces glucose-induced oxidative stress mediated by NAD(P)H oxidase via AMPK-dependent mechanism.
Ceolotto G; Gallo A; Papparella I; Franco L; Murphy E; Iori E; Pagnin E; Fadini GP; Albiero M; Semplicini A; Avogaro A
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2627-33. PubMed ID: 17916771
[TBL] [Abstract][Full Text] [Related]
20. Berberine Pretreatment Confers Cardioprotection Against Ischemia-Reperfusion Injury in a Rat Model of Type 2 Diabetes.
Chang W; Li K; Guan F; Yao F; Yu Y; Zhang M; Hatch GM; Chen L
J Cardiovasc Pharmacol Ther; 2016 Sep; 21(5):486-94. PubMed ID: 26846272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
